Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Randomized monocentric trial of efavirenz-, lopinavir/ritonavir-, or structured-rotation antiretroviral regimens in treatment-naive HIV-1 infection
2007-000526-48Phase 4Completed
- Sponsor
- AOU Policlinico di Modena
- Start
- Jul 2007
- Modality
- Small Molecules, Orthosteric Ligands → Classical Binding Small Molecules → Small Molecules
- Countries
- 1
01
Overview
Phase 4, randomised trial of efavirenz, lopinavir and ritonavir in human immunodeficiency virus infection (HIV) (3 arms), sponsored by AOU Policlinico di Modena. Primary endpoint: Comparison of toxicity, pharmacology, and adherence across three antiretroviral regimens. Started Jul 2007; status: completed.
02
Drugs
efavirenzlopinavirritonavir
03
Conditions
human immunodeficiency virus infection (HIV)
Beyond the preview
Go deeper on 2007-000526-48.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2007-000526-48.